BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:BLC - FR0000035370 - Common Stock
23.9 EUR
-0.1 (-0.42%)
Overall BLC gets a fundamental rating of 4 out of 10. We evaluated BLC against 30 industry peers in the Health Care Providers & Services industry. BLC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year BLC was profitable.
- In the past year BLC had a positive cash flow from operations.
- BLC had positive earnings in 4 of the past 5 years.
- In the past 5 years BLC always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of 0.08%, BLC is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
- The Return On Equity of BLC (0.74%) is worse than 66.67% of its industry peers.
- BLC has a better Return On Invested Capital (6.43%) than 63.33% of its industry peers.
- BLC had an Average Return On Invested Capital over the past 3 years of 6.14%. This is in line with the industry average of 6.46%.
- The last Return On Invested Capital (6.43%) for BLC is above the 3 year average (6.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.08% | ||
| ROE | 0.74% | ||
| ROIC | 6.43% |
ROA(3y)0.59%
ROA(5y)1.26%
ROE(3y)4.45%
ROE(5y)9.21%
ROIC(3y)6.14%
ROIC(5y)5.72%
1.3 Margins
- Looking at the Profit Margin, with a value of 0.11%, BLC is doing worse than 73.33% of the companies in the same industry.
- BLC's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 8.21%, BLC is doing good in the industry, outperforming 73.33% of the companies in the same industry.
- BLC's Operating Margin has been stable in the last couple of years.
- The Gross Margin of BLC (67.80%) is better than 76.67% of its industry peers.
- BLC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.21% | ||
| PM (TTM) | 0.11% | ||
| GM | 67.8% |
OM growth 3Y5.49%
OM growth 5Y0.75%
PM growth 3Y-66.74%
PM growth 5Y-48.72%
GM growth 3Y1.15%
GM growth 5Y6.69%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLC is creating some value.
- The number of shares outstanding for BLC remains at a similar level compared to 1 year ago.
- The number of shares outstanding for BLC remains at a similar level compared to 5 years ago.
- The debt/assets ratio for BLC has been reduced compared to a year ago.
2.2 Solvency
- BLC has an Altman-Z score of 1.39. This is a bad value and indicates that BLC is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of BLC (1.39) is worse than 70.00% of its industry peers.
- BLC has a debt to FCF ratio of 12.90. This is a negative value and a sign of low solvency as BLC would need 12.90 years to pay back of all of its debts.
- BLC has a Debt to FCF ratio of 12.90. This is in the lower half of the industry: BLC underperforms 60.00% of its industry peers.
- A Debt/Equity ratio of 5.29 is on the high side and indicates that BLC has dependencies on debt financing.
- BLC has a worse Debt to Equity ratio (5.29) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.29 | ||
| Debt/FCF | 12.9 | ||
| Altman-Z | 1.39 |
ROIC/WACC1.25
WACC5.15%
2.3 Liquidity
- BLC has a Current Ratio of 1.38. This is a normal value and indicates that BLC is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BLC (1.38) is better than 73.33% of its industry peers.
- A Quick Ratio of 1.18 indicates that BLC should not have too much problems paying its short term obligations.
- With a decent Quick ratio value of 1.18, BLC is doing good in the industry, outperforming 76.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.38 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
- BLC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 158.33%, which is quite impressive.
- The earnings per share for BLC have been decreasing by -46.37% on average. This is quite bad
- The Revenue has been growing slightly by 6.35% in the past year.
- BLC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.12% yearly.
EPS 1Y (TTM)158.33%
EPS 3Y-66.43%
EPS 5Y-46.37%
EPS Q2Q%-107.14%
Revenue 1Y (TTM)6.35%
Revenue growth 3Y1.6%
Revenue growth 5Y5.12%
Sales Q2Q%9.55%
3.2 Future
- The Earnings Per Share is expected to grow by 6.75% on average over the next years.
- BLC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y-4.33%
EPS Next 2Y0.96%
EPS Next 3Y6.75%
EPS Next 5YN/A
Revenue Next Year3.87%
Revenue Next 2Y4.87%
Revenue Next 3Y5.16%
Revenue Next 5Y7.69%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 341.43 indicates a quite expensive valuation of BLC.
- Based on the Price/Earnings ratio, BLC is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
- When comparing the Price/Earnings ratio of BLC to the average of the S&P500 Index (27.30), we can say BLC is valued expensively.
- A Price/Forward Earnings ratio of 11.89 indicates a reasonable valuation of BLC.
- 73.33% of the companies in the same industry are more expensive than BLC, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.32, BLC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 341.43 | ||
| Fwd PE | 11.89 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BLC is valued cheaper than 93.33% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BLC is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.53 | ||
| EV/EBITDA | 5.57 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y6.75%
5. Dividend
5.1 Amount
- BLC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BASTIDE LE CONFORT MEDICAL / BLC.PA FAQ
Can you provide the ChartMill fundamental rating for BASTIDE LE CONFORT MEDICAL?
ChartMill assigns a fundamental rating of 4 / 10 to BLC.PA.
Can you provide the valuation status for BASTIDE LE CONFORT MEDICAL?
ChartMill assigns a valuation rating of 4 / 10 to BASTIDE LE CONFORT MEDICAL (BLC.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for BASTIDE LE CONFORT MEDICAL?
BASTIDE LE CONFORT MEDICAL (BLC.PA) has a profitability rating of 5 / 10.
What is the expected EPS growth for BASTIDE LE CONFORT MEDICAL (BLC.PA) stock?
The Earnings per Share (EPS) of BASTIDE LE CONFORT MEDICAL (BLC.PA) is expected to decline by -4.33% in the next year.
Can you provide the dividend sustainability for BLC stock?
The dividend rating of BASTIDE LE CONFORT MEDICAL (BLC.PA) is 0 / 10 and the dividend payout ratio is 106.75%.